CA2915174C - Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions - Google Patents

Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions Download PDF

Info

Publication number
CA2915174C
CA2915174C CA2915174A CA2915174A CA2915174C CA 2915174 C CA2915174 C CA 2915174C CA 2915174 A CA2915174 A CA 2915174A CA 2915174 A CA2915174 A CA 2915174A CA 2915174 C CA2915174 C CA 2915174C
Authority
CA
Canada
Prior art keywords
skin
seq
composition
tetrapeptide
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2915174A
Other languages
English (en)
French (fr)
Other versions
CA2915174A1 (en
Inventor
Lijuan Zhang
Robin Carmichael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helix Biomedix Inc
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of CA2915174A1 publication Critical patent/CA2915174A1/en
Application granted granted Critical
Publication of CA2915174C publication Critical patent/CA2915174C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
CA2915174A 2013-06-14 2014-05-14 Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions Active CA2915174C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361835424P 2013-06-14 2013-06-14
US61/835,424 2013-06-14
PCT/US2014/037978 WO2014200651A1 (en) 2013-06-14 2014-05-14 Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions

Publications (2)

Publication Number Publication Date
CA2915174A1 CA2915174A1 (en) 2014-12-18
CA2915174C true CA2915174C (en) 2019-10-29

Family

ID=50943603

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2915174A Active CA2915174C (en) 2013-06-14 2014-05-14 Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions

Country Status (21)

Country Link
US (1) US10195245B2 (enExample)
EP (1) EP3007716B1 (enExample)
JP (1) JP6416240B2 (enExample)
KR (1) KR102254260B1 (enExample)
CN (1) CN105324122B (enExample)
AR (1) AR096594A1 (enExample)
AU (1) AU2014278708B2 (enExample)
BR (1) BR112015031018B1 (enExample)
CA (1) CA2915174C (enExample)
CY (1) CY1119191T1 (enExample)
DK (1) DK3007716T3 (enExample)
ES (1) ES2631804T3 (enExample)
HU (1) HUE032970T2 (enExample)
MX (1) MX362846B (enExample)
MY (1) MY168981A (enExample)
PL (1) PL3007716T3 (enExample)
RU (1) RU2687151C2 (enExample)
SG (1) SG11201509048VA (enExample)
SI (1) SI3007716T1 (enExample)
TW (1) TWI511737B (enExample)
WO (1) WO2014200651A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110302088A (zh) * 2019-04-29 2019-10-08 杭州肽佳生物科技有限公司 一种包含修饰芋螺肽的化妆品组合物
AU2021211840B2 (en) * 2020-01-21 2024-08-29 Asc Regenity Ltd Cosmetic formulation for topical administration comprising novel peptides that improve appearance and regeneration of skin
PL245202B1 (pl) 2020-03-06 2024-06-03 Gdanski Univ Medyczny Lipopeptydowe koniugaty i ich sole, sposób wytwarzania lipopeptydowych koniugatów i ich soli, kompozycja farmaceutyczna zawierająca lipopeptydowy koniugat i jego sole do leczenia ran przewlekłych
WO2022098051A1 (ko) 2020-11-05 2022-05-12 한국생명공학연구원 항염 및 조직 재생작용을 갖는 신규 펩타이드
CN113698452B (zh) * 2021-08-23 2023-08-18 四川丽妍工坊生物科技有限公司 一种促皮肤修复肽、制备方法及其应用
EP4426715A1 (en) * 2021-11-02 2024-09-11 Enumita AS Tri-, tetra and pentapeptides, compositions thereof and their use in the therapy of psoriasis
US20240123022A1 (en) * 2021-12-16 2024-04-18 Ramakrishna Reddy ISANAKA A stable anti-angiogenic and anti-inflammatory pharmaceutical formulation and pharmaceutical combination for treatment and prevention of psoriasis
CN116407611A (zh) * 2021-12-29 2023-07-11 四川好医生攀西药业有限责任公司 一种多肽在制备预防或治疗皮肤损伤疾病产品上的应用
KR20230156265A (ko) 2022-05-03 2023-11-14 한국생명공학연구원 신규 펩타이드 및 이의 항염 및 재생 용도
KR20240086709A (ko) * 2022-11-18 2024-06-19 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT62312A (en) * 1990-03-05 1993-04-28 Cephalon Inc Process for producing chymotrypsin-like proteases and their inhibitors
FR2814076B1 (fr) * 2000-09-21 2002-12-20 Centre Nat Rech Scient Agent angiogenique et ses utilisations
WO2007026356A2 (en) 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
PL2027152T3 (pl) 2006-06-13 2012-04-30 Helix Biomedix Inc Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej
JP2007001981A (ja) * 2006-07-10 2007-01-11 Nippon Meat Packers Inc 皮膚組織の再生及び肌質改善効果のあるペプチドを含有する化粧品
EP2125878B1 (en) 2007-01-05 2013-02-20 Helix Biomedix, Inc. Short bio-active peptides for cellular and immunological modulation
PL2205623T3 (pl) 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
EP2109054A1 (en) * 2008-04-09 2009-10-14 Biotempt B.V. Methods for identifying biologically active peptides and predicting their function
TWI429451B (zh) * 2011-10-26 2014-03-11 Nat Univ Tsing Hua 對具有elr-cxc趨化素高度親和力的受體蛋白細胞所引發疾病之拮抗治療劑

Also Published As

Publication number Publication date
AU2014278708A1 (en) 2015-12-24
BR112015031018A2 (pt) 2018-09-25
KR20160018595A (ko) 2016-02-17
US20160184384A1 (en) 2016-06-30
ES2631804T3 (es) 2017-09-05
RU2687151C2 (ru) 2019-05-07
SI3007716T1 (sl) 2017-09-29
RU2015146679A (ru) 2017-07-17
CN105324122B (zh) 2019-08-27
TWI511737B (zh) 2015-12-11
KR102254260B1 (ko) 2021-05-20
US10195245B2 (en) 2019-02-05
MX2015017089A (es) 2016-04-11
RU2015146679A3 (enExample) 2018-03-21
MX362846B (es) 2019-02-19
AU2014278708B2 (en) 2017-12-07
CN105324122A (zh) 2016-02-10
HK1217436A1 (en) 2017-01-13
AR096594A1 (es) 2016-01-20
EP3007716B1 (en) 2017-04-26
DK3007716T3 (en) 2017-07-31
CY1119191T1 (el) 2018-02-14
JP2016521746A (ja) 2016-07-25
HUE032970T2 (en) 2017-11-28
WO2014200651A1 (en) 2014-12-18
SG11201509048VA (en) 2015-12-30
TW201503896A (zh) 2015-02-01
MY168981A (en) 2019-01-29
CA2915174A1 (en) 2014-12-18
JP6416240B2 (ja) 2018-10-31
PL3007716T3 (pl) 2017-09-29
EP3007716A1 (en) 2016-04-20
BR112015031018B1 (pt) 2023-03-07
US20170007662A2 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
EP3007716B1 (en) Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions
CA2898717C (en) Short bio-active peptides for promoting wound healing
AU2013235692B2 (en) Short antimicrobial lipopeptides
ZHANG et al. GCC PATENT APPLICATION
HK1217436B (en) Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions
HK1212243B (en) Short bio-active peptides for promoting wound healing
KR101178497B1 (ko) 노나펩타이드 유도체를 함유하는 화장료 조성물

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170306

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250326

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250326

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250326

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260625